Mercury Biopharmaceutical Revenue

Mercury Biopharmaceutical had revenue of 4.72M TWD in the half year ending June 30, 2024. This brings the company's revenue in the last twelve months to 5.75M, up 114.55% year-over-year. In the year 2023, Mercury Biopharmaceutical had annual revenue of 1.03M, down -61.46%.

Revenue (ttm)

5.75M

Revenue Growth

+114.55%

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

n/a

Market Cap

6.70B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1.03M	-1.65M	-61.46%
Dec 31, 2022	2.68M	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
PharmaEssentia	8.32B
Caliway Biopharmaceuticals	49.98M
Bora Pharmaceuticals Co., LTD.	16.71B
Lotus Pharmaceutical	17.59B
Lumosa Therapeutics	37.82M
Oneness Biotech	112.20M
Polaris Group	75.65M
Center Laboratories	1.57B

Revenue Rankings